SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

ThermoGenesis Holdings, Inc. – ‘10-K’ for 12/31/19 – ‘EX-4.8’

On:  Monday, 3/23/20, at 8:32pm ET   ·   As of:  3/24/20   ·   For:  12/31/19   ·   Accession #:  1437749-20-5945   ·   File #:  333-82900

Previous ‘10-K’:  ‘10-K’ on 3/26/19 for 12/31/18   ·   Next:  ‘10-K/A’ on 4/24/20 for 12/31/19   ·   Latest:  ‘10-K’ on 4/16/24 for 12/31/23   ·   7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/24/20  ThermoGenesis Holdings, Inc.      10-K       12/31/19   89:9M                                     RDG Filings/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    865K 
 2: EX-4.8      Instrument Defining the Rights of Security Holders  HTML     39K 
 3: EX-21.1     Subsidiaries List                                   HTML     25K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML     28K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 7: EX-32       Certification -- §906 - SOA'02                      HTML     28K 
88: R1          Document And Entity Information                     HTML     65K 
38: R2          Consolidated Balance Sheets                         HTML    137K 
30: R3          Consolidated Balance Sheets (Parentheticals)        HTML     55K 
55: R4          Consolidated Statements of Operations and           HTML    114K 
                Comprehensive Loss                                               
86: R5          Consolidated Statements of Stockholders' Equity     HTML     84K 
                (Unaudited)                                                      
37: R6          Consolidated Statements of Cash Flows               HTML    138K 
29: R7          Note 1 - Description of Business, Going Concern     HTML     54K 
                and Basis of Presentation                                        
58: R8          Note 2 - Summary of Significant Accounting          HTML    232K 
                Policies                                                         
84: R9          Note 3 - Intangible Assets and Goodwill             HTML    117K 
33: R10         Note 4 - Equipment and Leasehold Improvements, Net  HTML     48K 
24: R11         Note 5 - Related Party Transactions                 HTML     58K 
49: R12         Note 6 - Convertible Promissory Note                HTML     59K 
78: R13         Note 7 - Derivative Obligations                     HTML     57K 
34: R14         Note 8 - Commitments and Contingencies              HTML     52K 
25: R15         Note 9 - Leases                                     HTML     49K 
50: R16         Note 10 - Stockholders' Equity                      HTML    133K 
79: R17         Note 11 - Concentrations                            HTML     44K 
35: R18         Note 12 - Segment Reporting                         HTML     85K 
23: R19         Note 13 - Income Taxes                              HTML     79K 
68: R20         Note 14 - Employee Retirement Plan                  HTML     30K 
75: R21         Note 15 - Subsequent Events                         HTML     34K 
46: R22         Significant Accounting Policies (Policies)          HTML    329K 
19: R23         Note 2 - Summary of Significant Accounting          HTML    131K 
                Policies (Tables)                                                
69: R24         Note 3 - Intangible Assets and Goodwill (Tables)    HTML    115K 
76: R25         Note 4 - Equipment and Leasehold Improvements, Net  HTML     46K 
                (Tables)                                                         
47: R26         Note 6 - Convertible Promissory Note (Tables)       HTML     35K 
20: R27         Note 7 - Derivative Obligations (Tables)            HTML     62K 
67: R28         Note 8 - Commitments and Contingencies (Tables)     HTML     37K 
77: R29         Note 9 - Leases (Tables)                            HTML     43K 
82: R30         Note 10 - Stockholders' Equity (Tables)             HTML    107K 
52: R31         Note 11 - Concentrations (Tables)                   HTML     37K 
22: R32         Note 12 - Segment Reporting (Tables)                HTML     85K 
32: R33         Note 13 - Income Taxes (Tables)                     HTML     68K 
81: R34         Note 1 - Description of Business, Going Concern     HTML     72K 
                and Basis of Presentation (Details Textual)                      
51: R35         Note 2 - Summary of Significant Accounting          HTML    100K 
                Policies (Details Textual)                                       
21: R36         Note 2 - Summary of Significant Accounting          HTML     68K 
                Policies - Revenues (Details)                                    
31: R37         Note 2 - Summary of Significant Accounting          HTML     31K 
                Policies - Remaining Performance Obligations                     
                (Details)                                                        
80: R38         Note 2 - Summary of Significant Accounting          HTML     62K 
                Policies - Remaining Performance Obligations 2                   
                (Details)                                                        
54: R39         Note 2 - Summary of Significant Accounting          HTML     39K 
                Policies - Anti-dilutive Securities (Details)                    
72: R40         Note 3 - Intangible Assets and Goodwill (Details    HTML     28K 
                Textual)                                                         
62: R41         Note 3 - Intangible Assets and Goodwill - Goodwill  HTML     42K 
                and Intangible Assets (Details)                                  
18: R42         Note 3 - Intangible Assets and Goodwill - Summary   HTML     71K 
                of Intangible Assets (Details)                                   
45: R43         Note 3 - Intangible Assets and Goodwill - Future    HTML     41K 
                Amortization Expense (Details)                                   
71: R44         Note 4 - Equipment and Leasehold Improvements, Net  HTML     27K 
                (Details Textual)                                                
61: R45         Note 4 - Equipment and Leasehold Improvements, Net  HTML     53K 
                - Summary of Property, Plant, and Equipment                      
                (Details)                                                        
17: R46         Note 5 - Related Party Transactions (Details        HTML    145K 
                Textual)                                                         
44: R47         Note 6 - Convertible Promissory Note (Details       HTML    107K 
                Textual)                                                         
70: R48         Note 6 - Convertible Promissory Note - Assumptions  HTML     38K 
                (Details)                                                        
63: R49         Note 7 - Derivative Obligations (Details Textual)   HTML     31K 
57: R50         Note 7 - Derivative Obligations - Fair Value        HTML     38K 
                Assumptions (Details)                                            
83: R51         Note 7 - Derivative Obligations - Fair Value        HTML     35K 
                Hierarchy (Details)                                              
39: R52         Note 7 - Derivative Obligations - Change in Fair    HTML     30K 
                Value of Derivative Liabilities (Details)                        
27: R53         Note 8 - Commitments and Contingencies (Details     HTML     58K 
                Textual)                                                         
59: R54         Note 8 - Commitments and Contingencies - Changes    HTML     35K 
                in Product Liability Included in Accrued                         
                Liabilities (Details)                                            
85: R55         Note 9 - Leases (Details Textual)                   HTML     42K 
40: R56         Note 9 - Leases - Lease Information (Details)       HTML     37K 
28: R57         Note 9 - Leases - Maturities of Lease Liabilities   HTML     43K 
                (Details)                                                        
56: R58         Note 10 - Stockholders' Equity (Details Textual)    HTML    196K 
87: R59         Note 10 - Stockholders' Equity - Warrant Activity   HTML     44K 
                (Details)                                                        
41: R60         Note 10 - Stockholders' Equity - Stock-based        HTML     35K 
                Compensation (Details)                                           
15: R61         Note 10 - Stockholders' Equity - Option Activity    HTML     68K 
                for Stock Option Plans (Details)                                 
64: R62         Note 10 - Stockholders' Equity - Non-vested Stock   HTML     49K 
                Options Activity (Details)                                       
73: R63         Note 10 - Stockholders' Equity - Schedule of        HTML     35K 
                Assumptions (Details)                                            
42: R64         Note 11 - Concentrations (Details Textual)          HTML     53K 
16: R65         Note 11 - Concentrations - Summary of Net           HTML     36K 
                Equipment by Geographic Area (Details)                           
65: R66         Note 12 - Segment Reporting (Details Textual)       HTML     26K 
74: R67         Note 12 - Segment Reporting - Summary of Operating  HTML     59K 
                Results by Reportable Segments (Details)                         
43: R68         Note 12 - Segment Reporting - Sales to Customers    HTML     36K 
                (Details)                                                        
14: R69         Note 13 - Income Taxes (Details Textual)            HTML     50K 
26: R70         Note 13 - Income Taxes - Reconciliation of Federal  HTML     50K 
                Income Tax Attributable to Operations to Income                  
                Tax Expense (Benefit) (Details)                                  
36: R71         Note 13 - Income Taxes - Components of Company's    HTML     65K 
                Deferred Tax Assets and Liabilities for Federal                  
                and State Income Taxes (Details)                                 
89: R72         Note 14 - Employee Retirement Plan (Details         HTML     28K 
                Textual)                                                         
60: R73         Note 15 - Subsequent Events (Details Textual)       HTML     48K 
53: XML         IDEA XML File -- Filing Summary                      XML    166K 
66: EXCEL       IDEA Workbook of Financial Reports                  XLSX     92K 
 8: EX-101.INS  XBRL Instance -- thmo-20191231                       XML   2.84M 
10: EX-101.CAL  XBRL Calculations -- thmo-20191231_cal               XML    170K 
11: EX-101.DEF  XBRL Definitions -- thmo-20191231_def                XML   1.66M 
12: EX-101.LAB  XBRL Labels -- thmo-20191231_lab                     XML   1.37M 
13: EX-101.PRE  XBRL Presentations -- thmo-20191231_pre              XML   1.69M 
 9: EX-101.SCH  XBRL Schema -- thmo-20191231                         XSD    232K 
48: ZIP         XBRL Zipped Folder -- 0001437749-20-005945-xbrl      Zip    236K 


‘EX-4.8’   —   Instrument Defining the Rights of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:  <>  <> 

Exhibit 4.8

 

 

Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as amended

 

Our Certificate of Incorporation authorizes the issuance of up to 350,000,000 shares of common stock, par value $0.001 per share, and 2,000,000 shares of preferred stock, par value $0.001 per share. The rights and preferences of the preferred stock may be established from time to time by our board of directors.

 

As of December 31, 2019, ThermoGenesis Holdings, Inc. (the “Company,” “we,” “us,” and “our”) had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which was its common stock, par value $.001 per share.

 

The following description of our common stock is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our Sixth Amended and Restated Certificate of Incorporation, as amended (the Certificate of Incorporation), which is filed as an exhibit to our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and incorporated by reference herein.

 

Common Stock

 

Each holder of common stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders, except matters that relate only to one or more of the series of preferred stock, and each holder does not have cumulative voting rights. Accordingly, the holders of a majority of the shares of common stock entitled to vote in any election of directors can elect all of the directors standing for election, if they so choose. According to our Bylaws, all matters are decided by the vote of a majority in voting interest of the stockholders present in person or by proxy and voting at any meeting of the stockholders during which a quorum is present, except as otherwise provided in the Certificate of Incorporation, in the Bylaws or by law.

 

Subject to preferences that may be applicable to any then outstanding preferred stock, holders of common stock are entitled to receive ratably those dividends, if any, as may be declared from time to time by the board of directors out of legally available funds. In the event of our liquidation, dissolution or winding up, holders of common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any outstanding shares of preferred stock.

 

Holders of common stock have no preemptive or conversion rights or other subscription rights, and there are no redemption or sinking fund provisions applicable to the common stock. All outstanding shares of common stock are, and the shares of common stock offered by us in this offering, when issued and paid for, will be fully paid and nonassessable. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock which we may designate in the future.

 

 

 

Effect of Certain Provisions of our Certificate of Incorporation and Bylaws and the Delaware Anti-Takeover Statute

 

Certificate of Incorporation and Bylaws

 

Some provisions of Delaware law and our Certificate of Incorporation and Bylaws contain provisions that could make the following transactions more difficult:

 

 

acquisition of us by means of a tender offer;

 

 

acquisition of us by means of a proxy contest or otherwise; or

 

 

removal of our incumbent officers and directors.

 

These provisions, summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids and to promote stability in our management. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors.

 

 

Undesignated Preferred Stock. The ability to authorize undesignated preferred stock makes it possible for our board of directors to issue one or more series of preferred stock with voting or other rights or preferences that could impede the success of any attempt to change control of us. These and other provisions may have the effect of deterring hostile takeovers or delaying changes in control or management of our company.

 

 

Stockholder Meetings. Our Bylaws provide that a special meeting of stockholders may be called only by the board of directors.

 

 

Requirements for Advance Notification of Stockholder Nominations and Proposals. Our Bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the direction of our board of directors or a committee of the board of directors.

 

 

Board of Directors Vacancies. Under our Bylaws, any vacancy on the board of directors, including a vacancy resulting from an enlargement of the board of directors, may be filled by vote of a majority of the remaining directors. The stockholders may elect a director or directors at any time to fill any vacancy or vacancies not filled by the directors.

 

 

Board of Directors Size. Under our Bylaws, the board of directors has the power to set the size of the board. The ability to increase or decrease the size of the board in conjunction with the other provisions above could make it more difficult for a third party to acquire control of the Company.

 

2

 

Delaware Anti-Takeover Statute

 

We are subject to Section 203 of the Delaware General Corporation Law (“DGCL”). This law prohibits a publicly held Delaware corporation from engaging in any business combination with any interested stockholder for a period of three years following the date that the stockholder became an interested stockholder, unless:

 

 

prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;

 

 

upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding those shares owned by persons who are directors and also officers and by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or

 

 

on or subsequent to the date of the transaction, the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder.

 

Section 203 defines “business combination” to include:

 

 

any merger or consolidation involving the corporation and the interested stockholder;

 

 

any sale, transfer, pledge or other disposition of 10% or more of our assets involving the interested stockholder;

 

 

in general, any transaction that results in the issuance or transfer by us of any of our stock to the interested stockholder; or

 

 

the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.

 

3

 

In general, Section 203 of the DGCL defines an “interested stockholder” as an entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person.

 

4


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed as of:3/24/208-K
Filed on:3/23/20
For Period end:12/31/1910-K/A,  3,  8-K,  CORRESP
 List all Filings 


7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/10/22  ThermoGenesis Holdings, Inc.      10-Q        9/30/22   54:4.6M                                   RDG Filings/FA
 8/11/22  ThermoGenesis Holdings, Inc.      10-Q        6/30/22   54:4.5M                                   RDG Filings/FA
 5/20/22  ThermoGenesis Holdings, Inc.      10-Q        3/31/22   50:3.4M                                   RDG Filings/FA
 4/29/22  ThermoGenesis Holdings, Inc.      S-1/A                  7:866K                                   RDG Filings/FA
 4/12/22  ThermoGenesis Holdings, Inc.      S-1         4/11/22    3:381K                                   RDG Filings/FA
 3/28/22  ThermoGenesis Holdings, Inc.      10-K       12/31/21   89:7.6M                                   RDG Filings/FA
 3/17/21  ThermoGenesis Holdings, Inc.      10-K       12/31/20   81:7M                                     RDG Filings/FA
Top
Filing Submission 0001437749-20-005945   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 4:21:21.1pm ET